Allworth Financial’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.81K Sell
670
-326
-33% -$4.65K ﹤0.01% 3880
2026
Q1
$16.7K Buy
996
+70
+8% +$1.25K ﹤0.01% 3122
2025
Q4
$14.8K Sell
926
-68
-7% -$1.01K ﹤0.01% 3000
2025
Q3
$12.3K Buy
994
+12
+1% +$141 ﹤0.01% 3010
2025
Q2
$11.3K Buy
982
+649
+195% +$7.7K ﹤0.01% 2836
2025
Q1
$3.87K Sell
333
-415
-55% -$6.95K ﹤0.01% 2900
2024
Q4
$14.7K Buy
748
+88
+13% +$1.7K ﹤0.01% 2285
2024
Q3
$12.2K Buy
660
+267
+68% +$5.36K ﹤0.01% 2178
2024
Q2
$9K Buy
393
+26
+7% +$460 ﹤0.01% 2263
2024
Q1
$6.27K Buy
367
+193
+111% +$3.04K ﹤0.01% 2311
2023
Q4
$3.07K Buy
+174
New +$3.51K ﹤0.01% 2483
2022
Q4
– Sell
-11
Closed – – 3041
2022
Q3
$0 Buy
11
+5
+83% +$84 ﹤0.01% 2706
2022
Q2
$0 Buy
+6
New +$159 ﹤0.01% 2442

Other funds holding CLB

Allworth Financial's CLB Position: Q2 2026 in Review

Allworth Financial reduced its Core Laboratories (CLB) stake by 33% in Q2 2026, selling an estimated $4.65K and leaving 670 shares worth $7.81K. The position accounts for ﹤0.01% of the portfolio, ranked #3880.

Allworth Financial first reported a position in CLB in Q2 2022 and has held it in 13 quarters since. The position peaked at $16.7K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Allworth Financial held 670 shares of Core Laboratories worth $7.81K as of Q2 2026.
  • Allworth Financial sold 326 Core Laboratories shares in Q2 2026, an estimated $4.65K.
  • Core Laboratories made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3880 holding.
  • Allworth Financial first reported a position in Core Laboratories in Q2 2022 and has held it in 13 quarters since.
  • Allworth Financial's Core Laboratories position peaked at $16.7K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.